Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.4/1721
Título: Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results
Autor: Silva, RM
Ruiz-Moreno, JM
Rosa, P
Carneiro, A
Nascimento, J
Rito, LF
Cachulo, ML
Carvalheira, F
Murta, JN
Palavras-chave: Inibidores da Angiogénese
Anticorpos Monoclonais
Neovascularização da Coróide
Miopia Degenerativa
Data: 2010
Citação: Retina. 2010;30(3):407-12. doi:
Resumo: PURPOSE: The purpose of this study was to evaluate the safety and efficacy of intravitreal ranibizumab after 12 months in the treatment of choroidal neovascularization secondary to pathologic myopia. METHODS: This was a prospective, multicenter, consecutive, nonrandomized, interventional case series. The study included 34 eyes of 32 patients with choroidal neovascularization secondary to pathologic myopia; 13 eyes had previous photodynamic therapy, and 21 eyes had no previous treatment. The patients were followed for > or = 12 months. Best-corrected visual acuity, optical coherence tomography, and the presence of metamorphopsia were assessed monthly. RESULTS: Mean visual acuity improved 8 letters from baseline to 12-month follow-up, and the difference was statistically significant (P < 0.001): 100% of the eyes lost <3 lines on the Early Treatment Diabetic Retinopathy Study chart, 24% of the eyes improved > or = 3 lines, 44% improved > or = 2 lines, 65% improved > or = 1 line, and 79% improved > or = 0 lines. Central retinal thickness decreased significantly from baseline to the 12-month follow-up (P < 0.01). A mean of 3.6 treatments were performed during the 12-month follow-up, and no systemic or ocular side effects were registered during that time. CONCLUSION: One-year results of intravitreal ranibizumab for myopic choroidal neovascularization are very promising. Additional prospective studies are necessary to better determine long-term efficacy and safety.
Peer review: yes
URI: http://hdl.handle.net/10400.4/1721
Aparece nas colecções:OFT - Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Intravitreal.pdf180,35 kBAdobe PDFVer/Abrir


Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.